EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Surgery compared to fibrinolytic therapy for symptomatic left-sided prosthetic heart valve thrombosis (SAFE-PVT): Rationale and design of a randomized controlled trial

Niveditha Devasenapathy, Velayoudam Devagourou, Milind P Hote, Palleti Rajashekar, Bharathraj Kidambi, Aayush Singal, Mohsin Raj Mantoo, Manoj Soni, Gaurav Purohit, Sandeep Singh, Ganesan Karthikeyan

Indian Heart Journal · 2024

DOI: 10.1016/j.ihj.2024.06.013 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Indian Heart Journal, 2024. Verfasst von Niveditha Devasenapathy und 10 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute of Global Health, New Delhi, India. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Thrombolytic Therapy, Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Left-sided mechanical prosthetic heart valve thrombosis (PVT) occurs because of suboptimal anticoagulation and is common in low-resource settings. Urgent surgery and fibrinolytic therapy (FT) are the two treatment options available for this condition. Urgent surgery is a high-risk procedure but results in successful restoration of valve function more often and is the treatment of choice in developed countries. In low-resource countries, FT is used as the default treatment strategy, though it is associated with lower success rates and a higher rate of bleeding and embolic complications. There are no randomized trials comparing the two modalities. METHODS: We performed a single center randomized controlled trial comparing urgent surgery (valve replacement or thrombectomy) with FT (low-dose, slow infusion tissue plasminogen activator, tPA) in patients with symptomatic left-sided PVT. The primary outcome was the occurrence of a complete clinical response, defined as discharge from hospital with completely restored valve function, in the absence of stroke, major bleeding or non-CNS systemic embolism. Outcome assessment was done by investigators blinded to treatment allocation. The principal safety outcome was the occurrence of a composite of in-hospital death, non-fatal stroke, non-fatal major bleed or non-CNS systemic embolism. Outcomes will be assessed both in the intention-to-treat, and in the as-treated population. We will also report outcomes at one year of follow-up. The trial has completed recruitment. CONCLUSION: This is the first randomized trial to compare urgent surgery with FT for the treatment of left-sided PVT. The results will provide evidence to help clinicians make treatment choices for these patients. (Clinical trial registration: CTRI/2017/10/010159).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisThrombolytic TherapyThrombosisAdultFemaleHumansMaleFibrinolytic AgentsFollow-Up StudiesHeart Valve DiseasesHeart Valve Prosthesis ImplantationRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

Fibrinolytic therapyProsthetic heart valve thrombosisRedo valve surgeryThrobectomyValve replacement surgery

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • The George Institute of Global Health, New Delhi, India.
  • Cardiothoracic Sciences Centre, All India Institute of Medical Sciences, New Delhi, India.
  • Cardiothoracic Sciences Centre, All India Institute of Medical Sciences, New Delhi, India; Translational Health Science and Technology Institute, Faridabad, Haryana, India. Electronic address: karthik2010@gmail.com.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Devasenapathy, N., Devagourou, V., Hote, M. P., Rajashekar, P., Kidambi, B., Singal, A., Mantoo, M. R., Soni, M., Purohit, G., Singh, S., & Karthikeyan, G. (2024). Surgery compared to fibrinolytic therapy for symptomatic left-sided prosthetic heart valve thrombosis (SAFE-PVT): Rationale and design of a randomized controlled trial. Indian Heart Journal. https://doi.org/10.1016/j.ihj.2024.06.013

Vancouver

Devasenapathy N, Devagourou V, Hote MP, Rajashekar P, Kidambi B, Singal A, et al. Surgery compared to fibrinolytic therapy for symptomatic left-sided prosthetic heart valve thrombosis (SAFE-PVT): Rationale and design of a randomized controlled trial. Indian Heart Journal. 2024. doi:10.1016/j.ihj.2024.06.013

BibTeX
@article{Devasenapathy2024,
  author = {Devasenapathy, Niveditha and Devagourou, Velayoudam and Hote, Milind P and Rajashekar, Palleti and Kidambi, Bharathraj and Singal, Aayush and Mantoo, Mohsin Raj and Soni, Manoj and Purohit, Gaurav and Singh, Sandeep and Karthikeyan, Ganesan},
  title = {Surgery compared to fibrinolytic therapy for symptomatic left-sided prosthetic heart valve thrombosis (SAFE-PVT): Rationale and design of a randomized controlled trial},
  journal = {Indian Heart Journal},
  year = {2024},
  doi = {10.1016/j.ihj.2024.06.013}
}
Kostenlos starten →